Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?
Journal articles
- Journal Article
Glass, LM; Hunt, CM; Fuchs, M; Su, GL
Published in: Fed Pract
February 2019
Improvement in NAFLD may lead to improvement of metabolic syndrome, cardiovascular disease, and malignancy and vice versa.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Fed Pract
ISSN
1078-4497
Publication Date
February 2019
Volume
36
Issue
2
Start / End Page
64 / 71
Location
United States
Citation
APA
Chicago
ICMJE
MLA
NLM
Glass, L. M., Hunt, C. M., Fuchs, M., & Su, G. L. (2019). Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? Fed Pract, 36(2), 64–71.
Glass, Lisa M., Christine M. Hunt, Michael Fuchs, and Grace L. Su. “Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?” Fed Pract 36, no. 2 (February 2019): 64–71.
Glass LM, Hunt CM, Fuchs M, Su GL. Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? Fed Pract. 2019 Feb;36(2):64–71.
Glass, Lisa M., et al. “Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both?” Fed Pract, vol. 36, no. 2, Feb. 2019, pp. 64–71.
Glass LM, Hunt CM, Fuchs M, Su GL. Comorbidities and Nonalcoholic Fatty Liver Disease: The Chicken, the Egg, or Both? Fed Pract. 2019 Feb;36(2):64–71.
Published In
Fed Pract
ISSN
1078-4497
Publication Date
February 2019
Volume
36
Issue
2
Start / End Page
64 / 71
Location
United States